Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAgeX Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
AgeX Therapeutics, Inc. Earnings Date And Information
AgeX Therapeutics, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 5,000 for the quarter and had revenue of 142,000 for the year. AgeX Therapeutics, Inc. has generated $-14 earnings per share over the last year ($-13.72 diluted earnings per share) and currently has a price-to-earnings ratio of -1.48. AgeX Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 based on prior year's report dates.
AgeX Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2024 | Q1 2024 | -$3.38 | $5,000 | $5,000 | ||
| 03/22/2024 | Q4 2023 | -$3.20 | $56,000 | |||
| 11/14/2023 | Q3 2023 | -$5.01 | $46,000 | |||
| 08/14/2023 | Q2 2023 | -$2.47 | $9,000 | |||
| 05/12/2023 | Q1 2023 | -$5.10 | $10,000 | |||
| 03/31/2023 | Q4 2022 | -$2.51 | $8,000 | |||
| 11/10/2022 | Q3 2022 | -$3.08 | $9,000 | |||
| 08/12/2022 | Q2 2022 | -$3.38 | $12,000 | |||
| 05/13/2022 | Q1 2022 | -$3.12 | $5,000 | |||
| 03/29/2022 | Q4 2021 | -$2.00 | $27,000 | |||
| 11/12/2021 | Q3 2021 | -$1.81 | $24,000 | |||
| 08/13/2021 | Q2 2021 | -$2.29 | $37,000 | |||
| 05/17/2021 | Q1 2021 | -$1.95 | $56,000 | |||
| 03/31/2021 | Q4 2020 | -$2.27 | $505,000 | |||
| 11/16/2020 | Q3 2020 | -$2.36 | $434,000 | |||
| 08/14/2020 | Q2 2020 | -$2.50 | $414,000 | |||
| 05/14/2020 | Q1 2020 | -$2.96 | $515,000 | |||
| 03/30/2020 | Q4 2019 | -$2.52 | $549,000 | |||
| 11/14/2019 | Q3 2019 | -$2.99 | $411,000 | |||
| 08/14/2019 | Q2 2019 | -$2.87 | $380,000 |
AgeX Therapeutics, Inc. Earnings: FAQ's
When is AgeX Therapeutics, Inc.'s earnings date?
AgeX Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 based off last year's report dates.
How can I listen to AgeX Therapeutics, Inc.'s earnings conference
call?
The conference call for AgeX Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read AgeX Therapeutics, Inc.'s conference call transcript?
The conference call transcript for AgeX Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does AgeX Therapeutics, Inc. generate each year?
AgeX Therapeutics, Inc. (:AGE) has a recorded annual revenue of $142,000.
How much profit does AgeX Therapeutics, Inc. generate each year?
AgeX Therapeutics, Inc. (:AGE) has a recorded net income of $142,000. AgeX Therapeutics, Inc. has generated $-13.72 earnings per share over the last four quarters.
What is AgeX Therapeutics, Inc.'s price-to-earnings ratio?
AgeX Therapeutics, Inc. (:AGE) has a price-to-earnings ratio of -1.48 and price/earnings-to-growth ratio is -0.14.